GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » Buyback Yield %

Biovica International AB (STU:9II) Buyback Yield % : -6.32 (As of Dec. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biovica International AB Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Biovica International AB's current buyback yield was -6.32%.


Biovica International AB Buyback Yield % Historical Data

The historical data trend for Biovica International AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Buyback Yield % Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -12.64 -0.14 -47.96 -85.68

Biovica International AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -28.22

Competitive Comparison of Biovica International AB's Buyback Yield %

For the Biotechnology subindustry, Biovica International AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Biovica International AB's Buyback Yield % falls into.



Biovica International AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Biovica International AB's Buyback Yield for the fiscal year that ended in Apr. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 8.541) / 9.96899416
=-85.68%

Biovica International AB's annualized Buyback Yield for the quarter that ended in Jul. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 1.423) * 4 / 20.173344
=-28.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Jul. 2024) data.


Biovica International AB Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines